These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 37685279)
21. Prospective comparison of whole-body MRI with diffusion-weighted and conventional imaging for the follow-up of neuroendocrine tumors. Minon M; Soriano C; Morland D; Walter T; Lepage C; Tabarin A; Deblock M; Rousset P; Barbe C; Hoeffel C; Cadiot G Endocrine; 2020 Jan; 67(1):243-251. PubMed ID: 31564038 [TBL] [Abstract][Full Text] [Related]
22. Diagnostic work-up and advancement in the diagnosis of gastroenteropancreatic neuroendocrine neoplasms. Koffas A; Giakoustidis A; Papaefthymiou A; Bangeas P; Giakoustidis D; Papadopoulos VN; Toumpanakis C Front Surg; 2023; 10():1064145. PubMed ID: 36950054 [TBL] [Abstract][Full Text] [Related]
23. [Contemporary nuclear medicine diagnostics of neuroendocrine tumors]. Srp Arh Celok Lek; 2015; 143(1-2):108-15. PubMed ID: 25845263 [TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of [ Choi SJ; Choi SH; Lee DY; Lee JS; Kim DW; Jang JK Eur Radiol; 2022 Jul; 32(7):4628-4637. PubMed ID: 35092473 [TBL] [Abstract][Full Text] [Related]
25. Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis. Treglia G; Castaldi P; Rindi G; Giordano A; Rufini V Endocrine; 2012 Aug; 42(1):80-7. PubMed ID: 22350660 [TBL] [Abstract][Full Text] [Related]
26. [Implementation of multidisciplinary team in the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasm]. Zhang P; Shen L Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1205-1210. PubMed ID: 27928786 [TBL] [Abstract][Full Text] [Related]
27. Diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms by nuclear medicine: Update and future perspective. Ma X; Ding Y; Li W; Li Q; Yang H Front Oncol; 2022; 12():1061065. PubMed ID: 36483036 [TBL] [Abstract][Full Text] [Related]
28. Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification. Anlauf M Horm Metab Res; 2011 Nov; 43(12):825-31. PubMed ID: 22105474 [TBL] [Abstract][Full Text] [Related]
29. Qualitative and quantitative image analysis of CT and MR imaging in patients with neuroendocrine liver metastases in comparison to (68)Ga-DOTATOC PET. Flechsig P; Zechmann CM; Schreiweis J; Kratochwil C; Rath D; Schwartz LH; Schlemmer HP; Kauczor HU; Haberkorn U; Giesel FL Eur J Radiol; 2015 Aug; 84(8):1593-1600. PubMed ID: 25999064 [TBL] [Abstract][Full Text] [Related]
31. Identification of sequence polymorphisms in the displacement loop region of mitochondrial DNA as a risk factor for gastroenteropancreatic neuroendocrine neoplasm. Er LM; Wu ML; Gao Y; Wang SJ; Li Y J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27704598 [TBL] [Abstract][Full Text] [Related]
32. Somatostatin Receptor Targeted PET-CT and Its Role in the Management and Theranostics of Gastroenteropancreatic Neuroendocrine Neoplasms. Adnan A; Basu S Diagnostics (Basel); 2023 Jun; 13(13):. PubMed ID: 37443548 [TBL] [Abstract][Full Text] [Related]